NEUROBIOGEN has been working with an advisory network of researchers and clinical
experts specializing in brain & neurological diseases with long experience.
The research findings on NEUROBIOGEN's new drug candidate SeReMABI were published in ‘Nature Medicine’, an international prestigious academic journal, in 2014. Starting with this, we are continuing to publish research findings along with continuous R&D.